Skip to content

About us
Our focus
Team
Investors
Drug pipeline
News
Contact

Menu

About us
Our focus
Team
Investors
Drug pipeline
News
Contact

External consultant

Home / Team / External consultant

Dr. Reinier Schwietert

About

AGILeBiotics B.V. is a pharmaceutical company focusing on the development of novel antibiotics for the treatment of multi-drug resistant infections

Latest news

AGILeBiotics won the Investors Forum 2019 at the Dutch Life Sciences Conference

28 November 2019

AGILeBiotics has been awarded the EUSMI-H2020 grant for up-scale synthesis of pre-clinical antibiotic candidate Toframicin

14 October 2019

AGILeBiotics has received the Lead Development Voucher from the Netherlands Antibiotic Development Platform

12 July 2019

AGILeBiotics is now member of HollandBIO

27 June 2019

Copyright © 2018 AGILeBiotics | All Rights Reserved. | Webdevelopment Skitter